Heart failure is a complex clinical syndrome resulting from impairment of ventricular filling or
ejection of blood associated with symptoms of dyspnea, fatigue, and peripheral and/or …

Heart failure (HF) is a clinical syndrome of diverse etiologies and can be associated with
preserved, reduced, or mid-range ejection fraction (EF). In the community, heart failure with …

Heart failure (HF) is common, affecting 1% to 2% of the general population, 1–3 with the
prevalence rising to more than 10% in those aged more than 80 years. 1, 4 HF has a high …

In broad terms,“advanced” heart failure describes a clinical syndrome characterized by
persistent or progressive symptoms and ventricular dysfunction despite guideline-directed …

Heart failure with preserved ejection fraction (HFpEF) is a common clinical syndrome
associated with high rates of morbidity and mortality. Due to the lack of evidence-based …

Background—The contributions of risk factors and disease pathogenesis to heart failure with
preserved ejection fraction (HFPEF) versus heart failure with reduced ejection fraction …

Heart failure with preserved ejection fraction (HFpEF) is a prevalent condition with
substantial individual and societal burden. In this article, we review the current status of …

The incidence and prevalence of heart failure is increasing, especially heart failure with
preserved ejection fraction (HFpEF) relative to heart failure with reduced ejection fraction …

Although enormous strides have been made in understanding the pathophysiology and
refining the diagnostic criteria of HFpEF, there is currently no pharmacological therapy with …

Heart failure (HF) is an important cardiovascular disease because of its increasing
prevalence, significant morbidity, high mortality, and rapidly expanding health care cost. 1 …